YCF26· AI

Nxtcure Labs

The full-stack AI CRO for drug discovery.

ActiveChecked 18h ago

Batch: F26
Status, per YC: Active
Team size: Not listed
HQ: San Francisco, CA

In F2686 companies, 86% AI

nxtcure.com YC profile LinkedIn

Founders

Alessandro HammondFounder/CEO
Keanu ClarkFounder/CTO

Same space

Competitors

Closest in what they build, same category.

Harmonic DiscoveryS21Multi-targeted therapeutics to treat complex diseasesShared: healthcareActive
OriginW26AI and Data for Cancer TherapeuticsShared: drug, medicine, cancerActive

Adjacent

Overlapping tags, a different niche.

Also from F26 in AI

Batchmates in Fall 2026.

About Nxtcure Labs

Reinventing medicine from lab to drug discovery. NxtCure CRO- an AI-native, full-stack CRO built to take therapeutics from discovery to market faster. NxtCure Cancer- the all-in-one mobile platform guiding patients through the cancer journey. We’re building the operating system for the future of medicine.

San Francisco, CA, USA

Nxtcure Labs: questions

Which YC batch was Nxtcure Labs in?

Nxtcure Labs was in Y Combinator's Fall 2026 batch (F26).

Is Nxtcure Labs still active?

Y Combinator lists Nxtcure Labs as active.

Who founded Nxtcure Labs?

Nxtcure Labs's founders, as listed on its YC page: Alessandro Hammond (Founder/CEO), Keanu Clark (Founder/CTO).

Where is Nxtcure Labs based?

Nxtcure Labs lists San Francisco, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.